Monitoring and managing a da Vinci surgery program to optimize quality and revenue requires a different level of data analytics, robotic surgery insights, and operational management – all virtually unknown to hospitals. CAVA Robotics has developed a proprietary, unprecedented, and prescriptive model that fills these needs and provides economic, clinical, and strategic opportunities for hospitals and IDNs across the US.
With the deepest, most complete body of robotics Comparative Cost-Effectiveness (CCE) analytics, management, and surgical insight ever developed, CAVA’s specialization in Robotics CCE can help your facility or hospital system rapidly and dramatically.
The widespread market adoption of the acclaimed da Vinci robot—despite its significant acquisition and maintenance costs and considerable program management challenges—is creating unprecedented economic, clinical, and strategic opportunities and issues for hospitals and IDNs across the U.S. The truth is, robotics programs are very difficult to monitor and manage financially, with the level of data analytics required to run these programs in a truly sustainable, long-term manner virtually unknown to most hospitals.
CAVA Robotics Change Management and Surgeon Leadership
As the leader in robotics Comparative Cost-Effectiveness analytics, CAVA has the deepest body of robotics CCE data, analytic tools, and supporting Change Management insight ever developed. CAVA’s proprietary Change Management program addresses 17 dimensions of robotics program improvement, supported by our proprietary Robotics Maturity Model.™ Analytics are the critical front-end diagnostic component to robotics program success; CAVA Robotics Change Management, driven by our renowned robotic surgeon leadership, provides step-by step, peer-to-peer support to our hospital and IDN clients, helping to apply what they learn from the analytics, and move their robotics program toward a model of clinical excellence, efficiency, economic sustainability, satisfying ROI, safety, and optimal outcomes.
CAVA Robotics Comparative Cost-Effectiveness analytics empowers you to assess clinical robotics categories including benign hysterectomy; radical prostatectomy; endometrial cancer; cardiothoracic, ENT, and general surgery applications (including single site laparoscopic cholecystectomy); anterior resection; and numerous other current and emerging robotics procedures.
World-Class Robotic Surgeon Leadership and Education
Lead by CAVA Robotics’ Medical Director Rick Low, MD, FACS, and supported by a team of highly experienced robotic surgeons and academic leadership expert in Cost-Effectiveness analytics, CAVA Robotics address both the economic and operational sides of the Robotics business, as well as provides robotics surgeons and administrators with the insight, education and know how to revolutionize their facility’s approach to the tactical deployment of robotic surgery. Learn things known by fewer than the top 1% of Robotics programs, and see the impact immediately – fiscally and procedurally.
Robotics Data Extraction
CAVA Robotics’ Data Extraction Team efficiently and quickly helps identify and capture our hospital clients’ comparative robotic vs. conventional lap vs. open data. These data often include Item Master and Charge Master extractions, EMRs, multiple and non-integrated data repository systems, patient chart reviews coordinated on-site by our nursing team, clinical leadership surveys and more. Support services can range from general guidance to advanced onsite data collection, dependent upon provider needs.
Through our customized online platform you’ll be able to determine a wealth of critical outputs to help your facility:
- Perform diagnostic (retrospective) and prescriptive (predictive) analyses on your existing or contemplated robotics programs
- Identify and quantify unknown costs, program inefficiencies, and performance problems
- Help you design a truly successful, sustainable, cost-effective robotics enterprise
- Address the appropriate usage of robotics within your surgical portfolio
- Determine viable robotics acquisition and deployment strategies
Clinical Robotics Assessment Categories Include
- Benign hysterectomy
- Radical prostatectomy
- General surgery (i.e., single site chole, inguinal and incisional hernia repairs, Nissen, lysis of adhesion)
- ENT procedures
- Endometrial cancer
- Numerous emerging robotics procedures
- Anterior and right colon resection
Schedule a 30-minute CAVA Robotics webinar demo with our senior leadership to discuss your facility’s Robotics program performance.
Sample CAVA Robotics application dashboards
CAVA Robotics CCE data and predictive modeling methodology
CAVA’s proprietary, predictive Comparative Cost-Effectiveness robotics models are designed based on clinical and economic evidence obtained from more than 6,000 robotic surgeries, 800 patient chart reviews across multiple US hospitals over the past 3 years, and in-depth interviews with robotics surgeons and hospital leaders. Our system’s benchmarking capabilities are being enhanced with data from new hospitals and IDNs on an ongoing basis, creating an every-expanding data set of unparalleled comparative robotics outcomes information.
CAVA Robotics streamlined 4-phase engagement process enables our hospital and IDN clients to move through their robotics program assessment and improvement program rapidly and efficiently, often as quickly as 8 to 12 weeks from start to completion.
CAVA Cost-Effectiveness analytics means the difference between a successful robotics program and a financial black hole and unforeseen risk
Simply put, the robotics Cost-Effectiveness information gap stands as a critical miss for hospitals in the US with a robotics program today, as well as for any hospital considering the purchase of a new da Vinci system and the ramp-up of a robotics program.
Robotics Comparative Cost-Effectiveness information represents the difference between a robotics program capable of economic success, and one destined to lose money year after year, even in the face of growing annual surgical volumes.
Most hospitals remain in the dark on these issues, and this blind spot is a costly one—compounding the multi-million dollar capital purchase/supply cost with an equally challenging ongoing operating loss.
- Ongoing fiscal monitoring
- Robotics program design and C-suite oversight
- Surgeon training, privilege design, quality metrics, and credentialing
- OR efficiency analysis and team training
- Ongoing data tracking and analysis methodologies, and much more…